MPs Push Routine Type 1 Tests; Minister Urges Caution
High-Level Summary
Westminster Hall debated e‑petition 728677 on routine testing for type 1 diabetes in infants, brought forward after the death of two‑year‑old Lyla Story. Members urged routine point‑of‑care finger‑prick testing when symptoms appear, wider professional and public awareness of the “four Ts”, and continued assessment of evidence from studies such as ELSA. The Minister said mandating immediate finger‑prick testing now would be “difficult to enact and could not be delivered quickly”, confirmed NICE will update paediatric guidance to raise the prominence of DKA risk, and outlined work on IT prompts and an education module for primary care. The motion that the House had considered the petition was agreed without division, and Lyla’s parents are to meet the Secretary of State “tomorrow”.
Detailed Summary
E‑petition 728677: Type 1 diabetes testing for infants (Westminster Hall)
Opening for the Petitions Committee, Irene Campbell set out the petition’s request: “Fund mandatory offer of testing for Type 1 Diabetes in babies, toddlers, and young children as a routine part of medical assessments at the point of care.” She described the campaign’s aims, including updating NICE guidance, adding information to the red book and a “test, don’t guess” framework, and noted research such as the ELSA study and statistics that “over a quarter of children aren’t diagnosed with type 1 diabetes until they are in diabetic ketoacidosis (DKA)”. Members from across the House recounted missed diagnoses and called for immediate blood‑glucose testing when symptoms suggest type 1, with Tom Gordon arguing that “finger‑prick blood‑glucose testing should be standard practice whenever a patient presents with symptoms suggestive of type 1 diabetes”. Sarah Bool pressed for equipment availability in primary care: “all GP practices actually have the finger‑prick test—the glucometer—available”, and others urged “a national public awareness campaign explaining the four Ts”. Some Members also queried organisational changes, asking, “With NHS England set to be abolished, how does the hon. Member suggest the Government ensure that awareness for testing for type 1 diabetes continues?” Screening and research were highlighted throughout, including references to ELSA and an announcement to “introduce a 10‑minute rule Bill on Tuesday 14 April” to propose a child screening programme.
Responding, the Minister, Sharon Hodgson, said that while work is under way to improve diagnosis, “a requirement for a mandatory finger‑prick test…is difficult to enact and could not be delivered quickly”. She outlined plans to use electronic patient records to “provide prompts for GPs to consider type 1 diabetes when particular symptoms are added” and to develop a primary‑care education module. She added that NICE “will update the guidance and guidelines” on paediatric diabetes “to raise the prominence of the risk of diabetic ketoacidosis”, and noted that the National Screening Committee “does not currently recommend screening” but “will consider whether a fresh review of the evidence for type 1 diabetes screening should be undertaken” after NICE’s teplizumab recommendation. On treatment, the Minister reported progress on technology uptake: “the use of HCLs in children under 19 has now increased from 36% in 2023‑24 to 70% in 2025‑26.” She also said work was being considered on the red book to raise parental awareness and reassured Members about NHS England changes, saying policy functions would transfer to the Department as appropriate. The Chair then put the Question, which was agreed to—“Question put and agreed to.”—and the House resolved that it had considered the petition. The Minister confirmed that John and Emma Story “will be meeting the Secretary of State for Health tomorrow”.